Abbasifard Mitra, Ostad Ebrahimi Hamid, Taghipur Khajeh Sharifi Gholamhosein, Bahrehmand Fatemeh, Bagheri-Hosseinabadi Zahra
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Department of Paediatrics, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Hum Immunol. 2025 Jan;86(1):111208. doi: 10.1016/j.humimm.2024.111208. Epub 2024 Dec 11.
Dysregulated levels of cytokines may lead to cytokine storm, which has been implicated in the immunopathogenesis of coronavirus disease 2019 (COVID-19). Here in the current study, the role of microRNA (miR)-155-5p, miR-146a, and miR-221-3p in the regulation of the immune responses and inflammatory state in patients with COVID-19 was investigated.
In this case-control study, peripheral blood samples were obtained from 75 COVID-19 subjects and 100 healthy controls. From the plasma samples, RNA was extracted and cDNA was synthesized, and subsequently the transcript level of miRNAs was measured by Real-time PCR. The plasma levels of interleukin (IL)-4 and interferon (IFN)-γ were determined using ELISA.
miR-155-5p (fold change = 1.87, P = 0.020) and miR-221-3p (fold change = 2.26, P = 0.008), but not miR-146a, was upregulated in the plasma sample of COVID-19 cases compared to controls. The level of IFN-γ (but not IL-4) was significantly higher in the plasma samples of COVID-19 patients compared to control group. The expression level of miR-155-5p (r = 0.35, corrected P = 0.066) and miR-221-3p (r = 0.25, corrected P = 0.066) had positive correlation with the plasma levels of IFN-γ.
IFN-γ pathway in involved in the pathogenesis of COVID-19 that is regulated through miR-155-5p and miR-221-3p. These miRNAs showed potential utility as biomarkers for predicting the severity of COVID-19.
细胞因子水平失调可能导致细胞因子风暴,这与2019冠状病毒病(COVID-19)的免疫发病机制有关。在本研究中,研究了微小RNA(miR)-155-5p、miR-146a和miR-221-3p在调节COVID-19患者免疫反应和炎症状态中的作用。
在这项病例对照研究中,从75名COVID-19患者和100名健康对照者中采集外周血样本。从血浆样本中提取RNA并合成cDNA,随后通过实时PCR测量miRNA的转录水平。使用酶联免疫吸附测定法测定血浆中白细胞介素(IL)-4和干扰素(IFN)-γ的水平。
与对照组相比,COVID-19患者血浆样本中miR-155-5p(倍数变化=1.87,P=0.020)和miR-221-3p(倍数变化=2.26,P=0.008)上调,而miR-146a未上调。与对照组相比,COVID-19患者血浆样本中IFN-γ(而非IL-4)水平显著更高。miR-155-5p(r=0.35,校正P=0.066)和miR-221-3p(r=0.25,校正P=0.066)的表达水平与血浆中IFN-γ水平呈正相关。
IFN-γ通路参与COVID-19的发病机制,其通过miR-155-5p和miR-221-3p进行调节。这些miRNA显示出作为预测COVID-19严重程度生物标志物的潜在效用。